Neurological Associates of Long Island
Lake Success, New York, United States
Doctor in North New Hyde Park, New York
1991 Marcus Ave, New Hyde Park, NY 11042
About Neurological Associates of Long Island
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
2
Avid Radiopharmaceuticals
1
IMS HEALTH GmbH & Co. OHG
1
Supernus Pharmaceuticals, Inc.
1
Tetra Discovery Partners
1
vTv Therapeutics
1
Clinical Trials at Neurological Associates of Long Island
During the past decade, Neurological Associates of Long Island conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on
average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif®
2016-02-01
2018-02-01
Completed
479
Registry of Amyloid Positive Patients for Alzheimer's Disease Drug Research Trials
2016-10-01
2017-10-18
Completed
317
Efficacy and Safety Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)
2018-06-06
2023-02-17
Terminated
1,054
Tetra PICASSO AD Trial: Study to Evaluate Effects of BPN14770 in Early Alzheimer's Subjects
2019-04-30
2020-02-01
Unknown status
255
Clinical Outcome Assessment of Parkinson's Disease Patients Treated With XADAGO (Safinamide)
2017-11-30
2020-01-10
Completed
164
Study of Azeliragon in Patients With Mild Alzheimer's Disease and Impaired Glucose Tolerance
2019-06-27
2021-01-29
Terminated
43
A Study to Evaluate the Safety, Tolerability, and Efficacy of Long-Term Gantenerumab Administration in Participants With Alzheimer's Disease (AD)
2021-02-01
2023-03-06
Terminated
1,379
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Neurological Associates of Long Island" #1 sponsor was "Hoffmann-La Roche" with 2 trials, followed by "Avid Radiopharmaceuticals" with 1 trials
sponsored, "IMS HEALTH GmbH & Co. OHG" with 1 trials sponsored, "Supernus Pharmaceuticals, Inc." with 1 trials sponsored and "Tetra Discovery Partners"
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Neurological Associates of Long Island"
#1 collaborator was "EMD Serono" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "PRA Health Sciences" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Neurological Associates of Long Island
According to Clinical.Site data, the most researched conditions in "Neurological Associates of Long Island" are
"Alzheimer Disease" (4 trials), "Alzheimer's Disease" (1 trials), "Cognition Disorders" (1 trials), "Idiopathic Parkinson Disease" (1 trials) and "Relapsing-remitting Multiple Sclerosis" (1 trials). Many other conditions were trialed in "Neurological Associates of Long Island" in a lesser frequency.
Clinical Trials Intervention Types at Neurological Associates of Long Island
Most popular intervention types in "Neurological Associates of Long Island" are "Drug" (7 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Gantenerumab" (2 trials), "Azeliragon" (1 trials), "BPN14770" (1 trials) and "Rebif" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Neurological Associates of Long Island
The vast majority of trials in "Neurological Associates of Long Island" are
7 trials for "All" genders.
Clinical Trials Status at Neurological Associates of Long Island
Currently, there are NaN active trials in "Neurological Associates of Long Island".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Neurological Associates of Long Island,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Neurological Associates of Long Island, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".